Literature DB >> 10512520

Increased p53 protein expression in human failing myocardium.

H Song1, J V Conte, A H Foster, J S McLaughlin, C Wei.   

Abstract

BACKGROUND: The p53 gene is a tumor-suppressor gene which involves apoptosis and cell-cycle arrest under certain stress stimulate. However, the status of the p53 gene expression in human myocardium in congestive heart failure (CHF) remains unclear. Therefore, the current study was designed to investigate the expression of the p53 protein in human myocardium in normal subjects and in patients with severe CHF.
METHODS: Human ventricular cardiac tissue was obtained from 7 normal subjects and 7 end-stage CHF patients during cardiac transplantation. The expression of p53 protein was determined by immunohistochemical staining. The cardiac apoptosis was determined by TUNEL staining.
RESULTS: The p53 protein was minimally stained in normal human ventricular cardiomyocytes. In contrast, the staining density and positive stained nuclear (%) of p53 was significantly increased in ventricular cardiomyocytes of patients with severe CHF. Apoptosis in CHF human myocardium also markedly increased.
CONCLUSIONS: The significantly increased expression of p53 in CHF human cardiomyocytes suggests that p53 may play an important pathophysiological role in the process of CHF through mechanisms involving myocardial apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512520     DOI: 10.1016/s1053-2498(98)00039-4

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  23 in total

1.  p53 regulates the cardiac transcriptome.

Authors:  Tak W Mak; Ludger Hauck; Daniela Grothe; Filio Billia
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

Review 2.  Sirtuin 3, Endothelial Metabolic Reprogramming, and Heart Failure With Preserved Ejection Fraction.

Authors:  Heng Zeng; Jian-Xiong Chen
Journal:  J Cardiovasc Pharmacol       Date:  2019-10       Impact factor: 3.105

3.  DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.

Authors:  Suet Nee Chen; Raffaella Lombardi; Jennifer Karmouch; Ju-Yun Tsai; Grace Czernuszewicz; Matthew R G Taylor; Luisa Mestroni; Cristian Coarfa; Priyatansh Gurha; Ali J Marian
Journal:  Circ Res       Date:  2019-03-15       Impact factor: 17.367

Review 4.  Different network pharmacology mechanisms of Danshen-based Fangjis in the treatment of stable angina.

Authors:  Guo-Xia Zhang; Ying-Ying Zhang; Xiao-Xu Zhang; Peng-Qian Wang; Jun Liu; Qiong Liu; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2018-02-08       Impact factor: 6.150

5.  S100A4 and P53 in myocardial collagen fibers of hypertrophic cardiomyopathy : Expression and clinical significance.

Authors:  X Qi; J Han; P Zhao; X Dong; S Gong
Journal:  Herz       Date:  2016-01-18       Impact factor: 1.443

6.  p53 and Mdm2 act synergistically to maintain cardiac homeostasis and mediate cardiomyocyte cell cycle arrest through a network of microRNAs.

Authors:  Shanna Stanley-Hasnain; Ludger Hauck; Daniela Grothe; Roozbeh Aschar-Sobbi; Sanja Beca; Jagdish Butany; Peter H Backx; Tak W Mak; Filio Billia
Journal:  Cell Cycle       Date:  2017-07-26       Impact factor: 4.534

Review 7.  Breaking down protein degradation mechanisms in cardiac muscle.

Authors:  Robert C Lyon; Stephan Lange; Farah Sheikh
Journal:  Trends Mol Med       Date:  2013-02-27       Impact factor: 11.951

Review 8.  A synopsis of research in cardiac apoptosis and its application to congestive heart failure.

Authors:  Ali Khoynezhad; Ziba Jalali; Anthony J Tortolani
Journal:  Tex Heart Inst J       Date:  2007

9.  ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes.

Authors:  Jiahao Liu; Weike Mao; Bo Ding; Chang-seng Liang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-05       Impact factor: 4.733

10.  Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53.

Authors:  Mary E Haywood; Andrea Cocciolo; Kadijah F Porter; Evgenia Dobrinskikh; Dobromir Slavov; Sharon L Graw; T Brett Reece; Amrut V Ambardekar; Michael R Bristow; Luisa Mestroni; Matthew R G Taylor
Journal:  J Mol Cell Cardiol       Date:  2020-01-18       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.